• Should you buy Liontown shares after its update?

    Liontown Resources Ltd (ASX: LTR) shares were on fire on Tuesday.

    The lithium developer’s shares ended the day 7% higher at 95.5 cents.

    The catalyst for this was news that the company has secured a US$250 million convertible note (CN) investment and 10-year offtake extension from foundational partner, LG Energy Solution.

    Broker reaction

    Bell Potter was pleased with the news and highlights that the company is now funded to steady-state production. It said:

    The CN increases LTR’s cash liquidity by $129m; it replaces the $550m debt facility announced in March 2024, of which $300m was allocated to repay a debt facility with offtake partner Ford. LTR will now retain the $300m Ford debt facility which has a 5-year tenor and BBSW+1.5% rate. LTR reiterated that Kathleen Valley remains on schedule for first production by the end of July 2024. With the CN, LTR will have available cash of $501m and remaining capex of around $120m to first production. LTR expects the $381m balance to fund Kathleen Valley to steady-state production, even under current depressed lithium pricing.

    The broker was pleased with the agreement and feels it was the right thing for management to do. Its analysts add:

    The LG CN funding is a pragmatic solution to remove the onerous terms associated with traditional bank debt and increase the company’s cash liquidity headroom. LTR’s 100% owned Kathleen Valley lithium project remains highly strategic with initial production imminent, a long mine life and tier-one location. LTR has offtake contracts with top tier EV and battery OEMs (Ford, LG Energy Solution and Tesla). Under our modelled assumptions, we expect that LTR is fully funded to free cash flow.

    Should you buy Liontown shares?

    If you have a high tolerance for risk, then Bell Potter thinks you should be considering an investment in Liontown’s shares. Especially if you are looking for exposure to the lithium industry.

    In response to this update, the broker has reaffirmed its speculative buy rating and $1.85 price target on the lithium developer’s shares. Based on its current share price of 95.5 cents, this implies potential upside of almost 95% for investors over the next 12 months.

    To put that into context, a $5,000 investment could turn into approximately $9,750 by this time next year if Bell Potter is on the money with its recommendation.

    Though, the broker warns: “LTR is an asset development company; our Speculative risk rating recognises this higher level of risk.”

    The post Should you buy Liontown shares after its update? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Liontown Resources right now?

    Before you buy Liontown Resources shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Liontown Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Brokers says these ASX 300 dividend shares are top buys

    There are a lot of ASX 300 dividend shares to choose from on the Australian share market.

    To narrow things down for income investors, I have picked out two that brokers have named as top buys recently.

    Let’s see what they are saying about these shares:

    Dexus Industria REIT (ASX: DXI)

    Over at Morgans, its analysts think that Dexus Industria could be an ASX 300 dividend share to buy this month. It is a real estate investment trust with a focus on industrial warehouses.

    The broker believes the industrial property company is well-placed due to solid demand, its development pipeline, and the positive rental growth outlook. It explains:

    The portfolio is valued at $1.6bn across +90 properties with 89% of the portfolio weighted towards industrial assets (WACR 5.38%). The portfolio’s WALE is around 6 years and occupancy 97.5%. Across the portfolio 50% of leases are linked to CPI with the balance on fixed increases between 3-3.5%. While we expect cap rates to expand further in the near term, DXI’s industrial portfolio remains robust with the outlook positive for rental growth. The development pipeline also provides near and medium-term upside potential and post asset sales there is balance sheet capacity to execute.

    In respect to income, the broker is forecasting dividends per share of 16.4 cents in FY 2024 and then 16.6 cents in FY 2025. Based on the current Dexus Industria share price of $2.84, this will mean dividend yields of 5.8% and 5.85%, respectively.

    Morgans has an add rating and $3.20 price target on its shares.

    Rural Funds Group (ASX: RFF)

    Analysts at Bell Potter think that Rural Funds could be an ASX 300 dividend share to buy. It is the owner of a portfolio of high-quality agricultural assets. This includes orchards, vineyards, water entitlements, cropping, and cattle farms.

    The broker believes that its shares are too cheap at current levels and sees this as a buying opportunity for income investors. It explains:

    RFF trades at a historical high discount to its market NAV per unit ($2.78 pu) at ~28%. While we are in general seeing large discounts to NAV in ASX listed farming and water assets to market NAV, the discount that RFF is trading appears excessive and we are seeing a valuable opportunity in RFF. While the timing of that value discount closing is difficult to call, investors are likely to be rewarded with a ~6% yield to hold the position until such a time as the asset class rerates. Furthermore, RFF aims to achieve income growth through productivity improvements, conversion of assets to higher and better use along with rental indexation which is built into all of its contracts with its tenants.

    As for dividends, Bell Potter is forecasting dividends per share of 11.7 cents in both FY 2024 and FY 2025. Based on the current Rural Funds share price of $2.00, this will mean yields of 5.85% for investors.

    The broker has a buy rating and $2.40 price target on its shares.

    The post Brokers says these ASX 300 dividend shares are top buys appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Dexus Industria Reit right now?

    Before you buy Dexus Industria Reit shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Dexus Industria Reit wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Rural Funds Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • After struggling to get pregnant, I have ‘next child’ anxiety

    Women holding and looking at newborn baby at hospital
    The author worries about what it will take to have another child, both financially and physically.

    • I was diagnosed with endometriosis and polycystic ovarian syndrome. 
    • I knew it would be complicated to get pregnant.
    • As soon as we had our first my husband and I started planning to have another baby. 

    A decade before I decided to have a baby, I was told that there would be complications.

    I was diagnosed with endometriosis and polycystic ovarian syndrome (PCOS), and my doctors were concerned about egg quality, anovulation, and other fertility issues. So when we did not get pregnant after a year, my husband and I began artificial reproductive treatment (ART).

    Even though my health insurance was exceptionally good and covered IVF with a few copays, the treatments failed over and over again. I experienced ovarian hyperstimulation syndrome (OHSS) and had to take weeks of bed rest to reduce the amount of fluid in my abdomen. This meant weeks out of work.

    Because of our insurance and extremely understanding and supportive employers, we did not have to worry about losing our jobs or accumulating medical debt. Nevertheless, we began to fear a reality where we did not have children.

    We switched clinics and I got pregnant

    Eventually, we decided to switch clinics after our first told us there was nothing left that they could do. At the new clinic, I had laparoscopic surgery to remove endometriosis lesions on my organs and to perform ovarian diathermy. The latter is a procedure during which your ovaries are lasered to lower your ovarian reserve with the hopes of the ovaries producing fewer but higher-quality eggs.

    Woman in hospital after fertility treatment
    The author worries about what it will take to have another child, both financially and physically.

    Two cycles later, as we waited on my period to begin egg retrieval three, I found out I was pregnant. Terrified and overjoyed, we cautiously navigated a surprisingly uncomplicated pregnancy. After nine long and anxious months, I had a whirlwind four-hour labor, and we met our son.

    But in the recovery room, my husband and I both began sharing anxieties about how we needed to structure our lives to have another child.

    I have anxiety about trying for another child

    I know this is not my reality alone. I have spoken with people in various support groups I have joined throughout my infertility and pregnancy journey about the next child anxiety.

    Next child anxiety is a fear of being retraumatized. It is a scale where we weigh the benefits of giving our child a sibling and the joys of having another child to love against the crushing reality of infertility and its treatments. It is figuring out how far you are willing to go into ART again and what the limits would look like. My surgery's effectiveness is typically two years, and over nine months have already been spent.

    As someone recently postpartum, it also feels unfair. My body has not been my own for two and a half years of treatment and nine months of pregnancy. But here I am, trying to plan.

    Then there is the career anxiety. Will we have infertility benefits? After my parental leave, I switched to remote work and lost the wonderful health insurance that had helped to change our lives. We have insurance now, but I am unsure how far it will go. I will always wonder if I left the chance to have another baby.

    In the infertility community, when you try to have a baby, you have to structure your entire life around this goal. It can mean a life of medical debt, moving to another state, or changing jobs or careers. And you are never guaranteed a child.

    The other day, I was thinking about my son in six years on vacation with us and an imagined sibling who would chase after him on the beach. But today I help him stack a tower of cups, watching his eyes dart in delight between me and the colorful toys. In a few months, I will call the clinic again and proceed on an uncertain path.

    Read the original article on Business Insider
  • Why Tesla stock continued to surge higher today

    A family drives along the road with smiles on their faces.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Reports of the demise of electric vehicle (EV) sales appear to have been exaggerated. At least that’s the conclusion that investors are drawing after Tesla (NASDAQ: TSLA) reported its second-quarter EV delivery numbers today.

    After the EV leader reported stronger-than-anticipated vehicle deliveries, Tesla shares led the S&P 500 gainers for the second straight day. As of 10:55 a.m. ET, the stock was up by 8.6% after jumping by more than 6% yesterday. Tesla stock was a beneficiary yesterday ahead of its report after several Chinese EV makers reported strong sales data. But there was even more to like than most anticipated from Tesla’s update today.

    Not just about EV sales

    Tesla delivered nearly 444,000 EVs in the second quarter. Investors had been reducing expectations throughout the period resulting in a consensus estimate of 439,000 units, according to FactSet. The reported figure was almost 5% lower than the year-ago period, but there were some positive facets of the report that investors may be focused on.

    In addition to beating estimates, the second quarter featured a drawdown in inventories as deliveries outpaced the 410,831 EVs it produced. A buildup of inventories due to lower perceived demand was a fear that helped drive Tesla’s share price down earlier this year. But the stock has now rebounded with a nearly 30% gain over just the last month.

    The good news from today’s report didn’t end there, either. The company noted a record 9.4 GWh (gigawatt hours) of energy storage products deployed in the three-month period. That more than doubled the previous record of 4.1 GWh reported in the first quarter.

    There’s been a surge in interest in energy storage products to smooth out power supply as renewable energy sources are installed for applications including growing data center construction.

    That surge in deployments bodes well for yet another source of revenue for Tesla. Investors will look for even more updates from the company when it reports full second-quarter financials on July 23 and provides an update on its self-driving technology on Aug. 8.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    The post Why Tesla stock continued to surge higher today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Tesla right now?

    Before you buy Tesla shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Tesla wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks *Returns as of 24 June 2024

    More reading

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended FactSet Research Systems and Tesla. Howard Smith has positions in Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Own NAB shares? You just got a 44% return in FY24

    A woman wearing a flowing red dress, poses dramatically on a beach with the sea in the background.

    Normally, the phrases ‘40% return’ and ‘bank shares’ aren’t uttered in the same sentence. ASX bank shares like National Australia Bank Ltd (ASX: NAB) are known for many things.

    Fat, fully franked, market-leading dividends would be the obvious choice. Stable, mature business models and multi-decade presences on the ASX could also be thrown around.

    But 40% returns in 12-month periods? That’s certainly a new one.

    Yet that’s exactly what NAB shares have delivered for their investors over the financial year just gone. Yep, NAB shares rose by a whopping 35.6% over the 2024 financial year.

    Want proof? Well, NAB shares started FY24 at $26.37 each. But by the time trading wrapped up last Friday, those same shares closed at $36.23. That’s a capital gain of 37.39% alone.

    If you want visual proof, just check out the graph below:

    But then we have to factor in NAB’s hefty dividend payments as well. Over the financial year that’s just passed us by, NAB doled out two fully franked dividend payments. As is the bank’s typical habit.

    Last July saw an interim dividend worth 83 cents per share paid out. Then we had December’s final dividend, worth 84 cents per share.

    Together, this $1.67 in dividends per share would have resulted in investors enjoying an additional yield of 6.33% over FY24, going off the bank’s FY24 starting price. So all up, investors have bagged a massive 43.7% in total gains from NAB shares last financial year.

    What about NAB shares in FY25?

    So NAB has had a phenomenal FY24. But what about the now-current financial year? Can investors expect another 40%-plus windfall from their NAB shares?

    Unfortunately, it doesn’t look good, at least according to some ASX experts.

    Last month, my Fool colleague Tristan covered the views of ASX broker UBS. UBS did note that it expects NAB to grow profits over both FY24 and FY25, which bodes well for NAB’s dividend payments. However, that wasn’t enough for UBS to hold back in issuing a ‘sell’ rating on the NAB share price.

    The broker simply sees NAB as “fully valued” at its current pricing, and gives the bank a 12-month share price target of $30. If realised, that would see investors take a 16% haircut from where the shares are today.

    Just over a month ago, we also looked at the view of another broker in Goldman Sachs. Goldman voiced similar concerns, noting that NAB “trades well above its 15-year average” and that all ASX banks are “close to record expensive”.

    Goldman gave NAB shares a neutral rating at the time, with a share price target of $34.04.

    So it seems most ASX experts aren’t liking what they see with NAB shares at the current price. That’s certainly something for investors to keep in mind after such a bumper FY24.

    The post Own NAB shares? You just got a 44% return in FY24 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in National Australia Bank Limited right now?

    Before you buy National Australia Bank Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and National Australia Bank Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor Sebastian Bowen has positions in National Australia Bank. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Top broker says Pilbara Minerals shares are ‘a super buy at these levels’

    Pilbara Minerals Ltd (ASX: PLS) shares have taken quite a beating over the past 12 months.

    Shares in the S&P/ASX 200 Index (ASX: XJO) lithium stock closed yesterday trading for $2.97 apiece. That sees the stock down more than 41% since this time last year, when shares were swapping hands for $5.06 each.

    That’s a far cry from the performance we witnessed in 2021, when the lithium miner’s shares leapt 288% over the calendar year.

    But things began heading downhill in late 2023. That’s when lithium prices fell off a cliff as surging supply growth began to outpace global demand growth for the battery-critical metal.

    For longer-term investors, however, the big selldown in Pilbara Minerals shares could represent a buying opportunity. One with a potential upside of more than 66%.

    That’s according to Richard Coppleson, director of institutional sales and trading at Bell Potter.

    According to Coppleson (quoted by The Australian Financial Review), “I own this and like it a lot. I think it’s a super buy at these levels. When lithium does recover, this is back to $5; only question is when will that be?”

    When will lithium prices recover?

    Like most market analysts, Coppleson is confident lithium prices will recover. Until then, though, it’s unlikely that Pilbara Minerals shares will rocket back to $5.

    On Tuesday, lithium carbonate was trading for US$12,800 a tonne.

    As for the outlook for global lithium prices, Citi forecasts that fast-building lithium inventories are likely to further pressure prices.

    “This high and rising low-shelf-life chemical inventories should see lithium prices fall another 15% to 20% to $US10,000 a tonne,” Citi global head of commodities research Max Layton said.

    But Citi expects lithium prices could begin to pick back up in 2025. According to Layton:

    A low-price environment over the next three to six months would force supply curtailments, driving physical markets to rebalance… Lithium consumption is expected to accelerate from 2025 onwards once the current negative EV sentiment fades.

    Advantage Pilbara Minerals shares?

    One advantage Pilbara Minerals shares could have over some of the miner’s rivals is the company’s comparatively low costs.

    “Pilbara’s relatively low unit costs have so far seen the company withstand softer pricing, providing a competitive advantage over others in the sector,” CEO Dale Henderson said when Pilbara reported its half-year results in February.

    And the company’s balance sheet remains strong, despite revenue dropping 27% year-on-year to $192 million in the March quarter. Management noted that fall reflected “a 28% decline in average realised price partly offset by a 3% increase in sales volume”.

    Pilbara Minerals had a cash balance of $1.8 billion as at 31 March.

    The post Top broker says Pilbara Minerals shares are ‘a super buy at these levels’ appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Pilbara Minerals Limited right now?

    Before you buy Pilbara Minerals Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Pilbara Minerals Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Is it time to buy FY24’s worst-performing ASX shares?

    With the end of a financial year and the beginning of a new one this week, it’s pertinent to look back on some of our share market’s best and worst stocks over the past 12 months and assess whether we should buy these ASX shares.

    On the weekend, my Fool colleague James named the worst-performing shares for FY24. They included Fletcher Building Ltd (ASX: FBU), Healius Ltd (ASX: HLS), Star Entertainment Group Ltd (ASX: SGR) and IGO Ltd (ASX: IGO). However, the worst performer on the index over FY24 was lithium stock Liontown Resources Ltd (ASX: LTR).

    These shares were dastardly performers over the 12 months to 30 June 2024. Liontown, in particular, lost its investors a painful 68%.

    As it happens, Liontown shares rallied more than 10% yesterday before news of a funding deal halted the shares. Still, this move comes too late to save the company from taking out the crown of thorns as the worst ASX 200 stock of FY24.

    But the more value-inclined investors out there might be sizing up these FY24 laggards today. After all, it was the legendary Waren Buffett who famously told us to “be greedy when others are fearful”. And investors were clearly mighty fearful of Fletcher Building, Healius, Star Entertainment, IGO and Liontown last financial year.

    Well, the good news for these value investors is that most of these shares are currently being eyed off by some ASX experts for their value potential.

    ASX experts rate some of the worst ASX shares of FY24 as a buy

    As reported in the Australian Financial Review (AFR) this week, Richard Coppleson, director of institutional sale and trading at Bell Potter, reckons the lithium sector is undervalued. Coppleson’s pick in lithium is the poor FY24 performer Pilbara Minerals Ltd (ASX: PLS) rather than Liontown:

    I own this and like it a lot… I think it’s a super buy at these levels – when lithium does recover, this is back to $5 – only question is when will that be?

    Star Entertainment is another beaten-down stock that has an enthusiastic backer. Atlantic Pacific Capital is reportedly a big fan of Star shares at their recent pricing. Fund manager Nicolas Bryon recently stated:

    If one were to read popular media, social media or the anonymous on chat forums, you would be convinced that this is potentially the worst decision in the world…

    Often those who don’t understand distressed investing will dump positions. This is true of institutional and retail investors alike … ultimately these assets are premium entertainment precincts. If operated well, they can earn above their cost of capital.

    Atlantic Pacific Capital joins other fund managers like Cooper Investors and L1 Capital in holding Star shares.

    Healius also has some fans amongst the ASX professional investing class. Maple-Brown Abbott, Perpetual Ltd (ASX: PPT) and Argo Investments Ltd (ASX: ARG) all retain significant stakes in Helius within their portfolios.

    But before we go, it’s worth keeping in mind another one of Warren Buffett’s best quotes:

    Mr. Market [the stock market] is there to serve you, not to guide you. It is his pocketbook, not his wisdom, that you will find useful. If he shows up some day in a particularly foolish mood, you are free to either ignore him or to take advantage of him, but it will be disastrous if you fall under his influence.

    Just because a share has had a disastrous year doesn’t mean it will bounce back in value. Sure, some beaten-down shares will end up getting oversold and might represent buying opportunities. But others are sold off for a very good reason and might end up being value traps.

    So make sure you follow Buffett’s advice and avoid getting ‘guidance’ from the share market. As he says, letting it guide our investing decisions is a path to disaster.

    The post Is it time to buy FY24’s worst-performing ASX shares? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Fletcher Building Limited right now?

    Before you buy Fletcher Building Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Fletcher Building Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor Sebastian Bowen has positions in Berkshire Hathaway. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Berkshire Hathaway. The Motley Fool Australia has recommended Berkshire Hathaway. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Buy Woolworths and these ASX dividend stocks

    If you are trying to decide which ASX dividend stocks to add to your income portfolio, then it could be worth looking at three listed below that analysts are bullish on.

    Here’s what you need to know about these income options:

    Healthco Healthcare and Wellness REIT (ASX: HCW)

    Analysts at Bell Potter think that Healthco Healthcare and Wellness REIT could be an ASX dividend stock to buy. It is a property company with a focus on health and wellness assets. This includes hospitals, aged care facilities, and primary care properties.

    The broker believes it is well-positioned to provide investors with some big dividend yields in the coming years. It is forecasting dividends per share of 8 cents in FY 2024 and then 8.3 cents in FY 2025. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.08, this will mean yields of 7.4% and 7.7%, respectively.

    Bell Potter has a buy rating and $1.50 price target on its shares.

    Stockland Corporation Ltd (ASX: SGP)

    Another ASX dividend stock that has been tipped as a buy is Stockland. It is Australia’s largest community creator, delivering a range of masterplanned communities and medium density housing in growth areas across the country.

    Citi is positive on the company and sees a lot of positives from its plan to acquire the communities business of Lendlease Group (ASX: LLC). It expects the addition to give Stockland’s earnings a boost in the near term.

    For now, though, the broker is forecasting dividends per share of 26.2 cents in FY 2024 and 26.6 cents in FY 2025. Based on the current Stockland share price of $4.17, this will mean yields of 6.3% and 6.4% yields, respectively.

    Citi has a buy rating and $5.10 price target on its shares.

    Woolworths Limited (ASX: WOW)

    Analysts at Goldman Sachs think that supermarket giant and Big W owner Woolworths could be an ASX dividend stock to buy. In fact, the broker is so positive on the retailer that it has its shares on its coveted conviction list.

    Goldman believes Woolworths’ shares are undervalued at current levels. Particularly given its belief that the company is positioned to deliver solid earnings and dividend growth in the coming years.

    In respect to the latter, the broker is forecasting fully franked dividends per share of $1.07 in FY 2024 and $1.13 in FY 2025. This equates to dividend yields of 3.2% and 3.4%, respectively.

    Goldman has a buy rating and $40.20 price target on its shares.

    The post Buy Woolworths and these ASX dividend stocks appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Healthco Healthcare And Wellness Reit right now?

    Before you buy Healthco Healthcare And Wellness Reit shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Healthco Healthcare And Wellness Reit wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Just 1 piece of evidence could scuttle Trump’s hush-money conviction and force a time-sucking retrial

    Donald Trump campaigning in in Racine, Wisconsin.
    Donald Trump could be in for a hush-money retrial.

    • Thanks to the SCOTUS immunity decision, it may not take much to force a hush-money retrial.
    • One key piece of evidence, People's Exhibit 81, may be enough to scuttle Trump's May 30 verdict.
    • It's an ethics form Trump signed in 2018, just the kind of official-act evidence SCOTUS now bans.

    It might not take much to scuttle Donald Trump's May 30 hush-money conviction.

    In fact, a single piece of evidence could be Trump's handiest monkey wrench of all.

    Manhattan prosecutors labeled it People's Exhibit 81.

    It's a routine federal ethics form called an "Executive Branch Personnel Public Financial Disclosure Report."

    Manhattan prosecutors showed it to jurors back in early May, during the third week of testimony.

    They later spun it as solid proof that Trump knew his hush-money reimbursement checks to his then-attorney, Michael Cohen, were just that: reimbursements, not "legal fees," as his falsified business records claimed.

    "Mr. Trump fully reimbursed Mr. Cohen in 2017," claimed the form, which attested to his assets and liabilities and bore his signature.

    Excerpt from a footnote in a financial disclosure form Donald Trump signed in 2018, reading, "Mr. Trump fully reimbursed Mr. Cohen in 2017."
    A footnote in a financial disclosure form Donald Trump signed in 2018.

    Days before closing arguments, Business Insider highlighted People's 81 as one of ten pieces of incriminating "smoking gun" evidence.

    Prosecutor Joshua Steinglass days later mentioned People's 81 in closing arguments, calling it proof that Trump "knew that the payments were really reimbursements."

    Donald Trump's signature on a 2018 financial disclosure form.
    Donald Trump's signature on People's Exhibit 81.

    Then came Monday.

    In a sweeping decision that fell just ten days before Trump's original sentencing date, the US Supreme Court declared former presidents presumptively immune from criminal prosecution for "official acts."

    Then the court went further, banning the use of official acts as evidence.

    An excerpt from the Supreme Court's immunity decision, saying that "Presidents therefore cannot be indicted based on conduct for which they are immune from prosecution."
    An excerpt from the Supreme Court's immunity decision.

    It took less than a day for defense lawyers to use this ban on "official act" evidence to challenge Trump's May 30 conviction. It's a challenge that has now delayed Trump's July 11 sentencing on the grounds that hush money prosecutors improperly used Trump's official acts against him at trial.

    People's Exhibit 81 — a financial disclosure form that must be filed by all senior US government officials, and which Trump only filed because he was president — is front and center in that defense effort.

    Other "official act" evidence the defense is now challenging includes Trump phone records and tweets, and an Oval Office conversation he had with Hope Hicks, his then-communications director.

    "Under Trump," defense lawyer Todd Blanche wrote Monday, referring to the SCOTUS decision, "this official-acts evidence should never have been put before the jury."

    Trump "may not be prosecuted for his exercising his core constitutional powers," Blanche wrote, continuing to quote from Monday's decision.

    Prosecutors with the office of Manhattan District Attorney Alvin Bragg quickly scoffed in response that Trump's efforts are "without merit."

    But they were not entirely meritless — Bragg and New York Supreme Court Justice Juan Merchan both agreed to push back Trump's July 11 sentencing date so the issue can be argued in a planned volley of papers.

    Trump will file his arguments by July 10, prosecutors will respond by July 24, and the judge will rule — deciding that the hush-money conviction stands or is overturned — on September 6.

    Under New York Criminal Procedure Law, Merchan must decide if the SCOTUS ruling "would require a reversal or modification of the judgment as a matter of law by an appellate court."

    "It would come down to two things," said Michel Paradis, an attorney who teaches national security and constitutional law at Columbia Law School.

    Was the evidence or testimony "official in some way," and therefore subject to this new immunity rule? And if so, was its use at trial "a harmless error."

    Trump's new sentencing date will be September 18, Merchan ruled — if sentencing is "still necessary" by that date.

    Why People's 81 may be Trump's best monkey-wrench

    In hopes of setting aside Trump's verdict, Trump's lawyers raised other instances where they say "official acts" were improperly used at trial against him.

    A big one is testimony by Trump's former communications director, Hope Hicks, who described to jurors Trump's reaction in the Oval Office, when news of Trump's hush-money payment to porn star Stormy Daniels first broke in 2018.

    "He wanted to know how it was playing," Hicks told the jury, referring to the news coverage.

    "And I think Mr. Trump's opinion was it was better to be dealing with it now, and that it would have been bad to have that story come out before the election," she told jurors.

    "That is devastating," Steinglass, the prosecutor, said of Hick's testimony, noting that it firmly linked the hush-money payment to the presidential election, a connection Trump had denied.

    Paradis said prosecutors may find themselves battling with the defense over how much of Hicks' Oval Office conversation with Trump was on an official topic, and therefore banned as testimony.

    Merchan — or, as is more likely, appeals judges down the line — may bar any prosecutorial use of the Hicks-Trump conversation merely because some of it may have touched on official acts, Paradis said.

    The defense is also signaling that it will challenge the use of certain incriminating tweets, including one from May, 2018, in which Trump again referred to his payments to Cohen as "reimbursement" for "a non-disclosure agreement," AKA hush money.

    A May 2018 tweet by then-President Donald Trump, in which he acknowledges that Michael Cohen received "reimbursement" for  a "non-disclosure agreement.
    Trump tweeted about a non-disclosure agreement in 2018.

    But these and other tweets the defense is raising as "official" were sent from Trump's personal Twitter account, and concerns, as Trump himself put it, "a private contract."

    Finally, the defense said Tuesday that it will challenge as "official" the prosecution's use of phone records "reflecting calls involving President Trump while he was in office."

    Again, as records of both personal and business calls, this evidence contains a mix of official and unofficial acts that must now be argued over before Merchan and any appellate judges that get the case.

    Prosecutors' best bet may be to argue that financial disclosure forms like People's 81 are "personnel documents," Paradis said — "which, in the bureaucracy of the federal government would likely be deemed 'personal.'"

    But whether that argument sinks or flies is anyone's guess, he told BI.

    "That is the thing about this decision," he added. "It does not come right out and say 'the president is immune from all prosecution.' In some ways, it is more pernicious than that," he said.

    "It just creates an immunity that is so ill-defined and so unmoored from any agreed-upon constitutional text or history, that there is no way of knowing its outer limits," he said.

    "And leaving so much uncertainty about the outer limits means, for all practical purposes, that those outer limits don't exist."

    Read the original article on Business Insider
  • The US Army wants to equip its next-gen Abrams tank with modern military tech — without the bulk

    M1A2 Abrams tank seen before a high-intensity training session
    M1A2 Abrams tank seen before a high-intensity training session

    • The US Army wants to modernize Abrams tank while cutting at least 20,000 pounds from its weight.
    • Upgrades to the new M1E3 Abrams could include an autoloader, stealth tech, and a new main gun.
    • But the Abrams' bulkiest features are the armor and protective systems that make it so formidable.

    A new contract decision is moving the US military's world-class Abrams tank in a direction it's never gone before: after decades of getting bulkier amid upgrades to add firepower and cutting-edge protection, it's finally getting a critically needed slim-down.

    Defense News was first to report at the end of May that the Army had awarded a contract to Abrams manufacturer General Dynamics Land Systems (GDLS) to start developing requirements for what it's calling the M1E3 — a new generation of Abrams tank.

    Reached for details on the contract, GDLS referred all questions to the Army's PEO Ground Combat Systems, which did not respond to Sandboxx News' queries. While the Defense Department published award notices for several smaller Abrams contract modifications in May, it appears the details of this design contract have not yet been made public.

    This begins a new era of development for the Abrams, and the first of its kind in decades: the last full M1A2 rolled off production lines in 1996. Yet, the task of rolling out a modernized tank — one that needs to cut more than 10 tons from its fighting weight — is formidable.

    The M1A2 Abrams is in a weight class of its own among the world's leading tanks: the current variant, the SEPv3, weighs around 70 tons on its own, and up to 78 with a full combat load. As a comparison point, 78 tons is also the maximum takeoff weight for the Airbus A320, a passenger aircraft with a capacity for 180 souls.

    Air Force airmen assigned to the 816th Expeditionary Airlift Squadron unload an Army M1A2 Abrams main battle tank off a C-17A Globemaster III aircraft at an undisclosed location within the U.S. Central Command area of responsibility, Aug. 27, 2022.
    Air Force airmen assigned to the 816th Expeditionary Airlift Squadron unload an Army M1A2 Abrams main battle tank off a C-17A Globemaster III aircraft at an undisclosed location within the US Central Command area of responsibility, Aug. 27, 2022.

    The heft of the Abrams tank has enabled its dominance as one of the most formidable main battle tanks in service; but as its weight has grown with each update, it has also started to limit its mobility.

    In 2017, a three-star Army general revealed to Congress that the tank could no longer be towed by the Heavy Equipment Transport vehicle specifically designed to tow it — meaning there was nothing that could haul the Abrams around Europe, where a number had been positioned as part of an initiative to deter Russia.

    Bridges are also a problem, particularly in Europe where many crossings are old and not reinforced; there, a single Abrams represents a major structural threat. With a current hot conflict in Europe, these drawbacks were increasingly concerning to planners. In September, the Army announced it was canceling a planned upgrade — the M1A2 Sepv4 — that threatened to fatten the Abrams even more, and instead pursue a more radical modernization.

    "The Abrams tank can no longer grow its capabilities without adding weight and we need to reduce its logistical footprint," Maj. Gen. Glenn Dean, program executive officer for the Army's Ground Combat Systems, said in a statement accompanying the announcement. "The war in Ukraine has highlighted a critical need for integrated protections for soldiers, built from within instead of adding on."

    M1A2 Abrams tank
    An M1A2 Abrams at the Army Armor School at Fort Benning in Georgia on April 29, 2022.

    To this end, the Army is asking for $246 million for the next fiscal year, with plans to spend another $366 million on tank upgrades in fiscal 2026. A paper developed by the Congressional Research Service lays out the Army's primary objectives for modernization. It cites a 2019 Army Science Board study that reportedly influenced the path the service is currently on.

    Some of them would merely adopt technologies already in use by other premier tanks, such as an autoloader, which might allow the Abrams to employ a crew of three instead of four and cut down on manpower. The French Leclerc and South Korean K2 Black Panther already have autoloaders, as do Russian, Japanese, and Chinese tanks. Also proposed is a new main gun in lieu of the Abrams' legacy 120mm L/44 M256 smoothbore armament.

    Other proposed features would enhance the Abrams' stealth; these include "masking" tech that reduces thermal and electromagnetic signatures and a hybrid-electric drive, a feature that typically enables silent standby mode.

    General Dynamics' AbramsX demonstrator, incorporated many of these features. It built in the autoloader and the hybrid drive and swapped in an XM360 tube on the main gun to cut the weapon's weight in half.

    In addition to other wish-list features, like better command-and-control capabilities and the ability to launch drones and network with unmanned and robotic systems, the AbramsX purportedly achieves the all-important slimdown the Army wants, weighing in at a comparatively svelte 60 tons. It achieves much of these savings by relocating the crew inside the hull, allowing for a major armor reduction on the turret.

    U.S. M1A2 "Abrams" tank moves to firing positions during U.S. led joint military exercise "Noble Partner 2016" near Vaziani
    US M1A2 "Abrams" tank moves to firing positions during US led joint military exercise "Noble Partner 2016" near Vaziani

    And herein lies the biggest challenge for the Army in its quest for a lighter tank: the bulkiest features the Abrams sports are the armor and protective systems that make it so formidable. The Abrams Reactive Armor Tiles that cover the tank's surface alone add two more tons of weight — but the tiles effectively blast incoming rockets away from the vehicle's surface, adding a next-level layer of protection.

    The Abrams' Trophy Active Protection System, an Israeli-developed countermeasure that detects and intercepts incoming threats much like a miniature Iron Dome, adds nearly four more tons. That reality has spurred speculation as to whether Trophy will be featured on future generations of the Abrams.

    The reality is that the M1 Abrams has gotten so heavy through its cycle of adding new protections onto its rugged frame as they become state-of-the-art: therefore, it is a cross-section of many of the best systems the world's tanks have to offer. To cut weight, the Army will have to undertake an aggressive redesign to make some of those systems internal to the vehicle; but it may also have to make some tough tradeoff decisions about what the next-generation Abrams truly needs to meet tomorrow's threats.

    It is left to be seen which features belong in Abrams' future, and which will be left in the past.

    READ MORE FROM SANDBOXX NEWS

    Read the original article on Business Insider